Fugazzotto Paul A
Int J Oral Maxillofac Implants. 2005 Jan-Feb;20(1):77-83.
Guided bone regenerative therapy has become a significant component of clinical implant practice. Initial reports have demonstrated success rates of implants in regenerated bone under function comparable to the success rates of implants placed in native nonregenerated host bone. This report documents the success and failure rates of osseointegrated implants placed in regenerated bone for up to 133 months in function.
A retrospective analysis of a group of 607 titanium plasma-sprayed cylindric implants placed in regenerated bone, the success and failure rates of which were previously reported at 6 to 51 months in function, were assessed.
The implants demonstrated cumulative success rates of 97.2% for the maxilla and 97.4% for the mandible, yielding an overall cumulative success rate of 97.4% for up to 133 months in function.
Titanium plasma-sprayed osseointegrated implants of various diameters, lengths, and designs, utilized in a variety of clinical scenarios, demonstrated functional cumulative success rates comparable to those of implants placed in nonregenerated host bone for extended periods of time in this patient population.
引导骨再生治疗已成为临床种植实践的重要组成部分。初步报告显示，在功能状态下，种植体在再生骨中的成功率与植入天然未再生宿主骨中的种植体成功率相当。本报告记录了在功能状态下植入再生骨长达133个月的骨整合种植体的成功率和失败率。
对一组607颗植入再生骨的钛等离子喷涂圆柱形种植体进行回顾性分析，评估其在6至51个月功能状态下的成功率和失败率。
上颌种植体的累积成功率为97.2%，下颌种植体的累积成功率为97.4%，在长达133个月的功能状态下，总体累积成功率为97.4%。
在该患者群体中，各种直径、长度和设计的钛等离子喷涂骨整合种植体，应用于多种临床情况，其功能累积成功率与长时间植入未再生宿主骨中的种植体相当。
